Login / Signup

Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.

Tiantian WangMiaofa YingRui ZhaoDanyan ZhuLiSan Zhang
Published in: Sleep & breathing = Schlaf & Atmung (2021)
The augmentation rate of the Chinese RLS patients in our study was 15%. Augmentation may be associated with switching from other dopaminergic drugs, long disease duration before pramipexole use, the dose and duration of pramipexole, and tolerance to pramipexole.
Keyphrases
  • end stage renal disease
  • soft tissue
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • stem cells
  • case report
  • mesenchymal stem cells